RNAx Inks Japanese Distribution Deal with Funakoshi

RNAx said this week that it has signed a deal under which its siRNA oligonucleotide and genetic target validation services will be marketed in Japan exclusively by Funakoshi.

“We are happy to be able to collaborate with Funakoshi to enter the very interesting Japanese market,” RNAx CEO Joerg Poetzsch said in a statement. “Experience has shown that local presence of native experts who are familiar with the customs of a given country plays a key role in successfully operating at a foreign market.”